Priya Kapoor Priya Kapoor Asked 7 months ago

When is her2-positive breast cancer most likely to recur?

My aunt recently had treatment for HER2-positive breast cancer, and she's worried about it coming back. We're trying to understand the prognosis better. At what stage or timeframe is HER2-positive breast cancer most likely to recur after treatment?

5

5 answers

Anuj Verma Anuj Verma Joined Apr 2026 7 months ago
Most liked

Oh man, that's a serious question. Probably when I'm trying to catch some sleep, and my brain decides to run a marathon of 'what ifs'. But seriously, for HER2-positive breast cancer, I hear it's often within the first few years after treatment, but it can vary. My 'medical' advice ends here, I need coffee.

Prakash Jain Prakash Jain Joined Jun 2026 4 months ago

Recurrence for HER2-positive breast cancer is something doctors monitor very closely. From what I've understood, it's often higher in the first 5 years post-treatment. Regular follow-ups, including scans and tests, are crucial. Make sure you plan for the costs of these tests, as they can be significant, and good health insurance helps a lot.

Powered by

Consult a radiation oncologist

Geeta Rao Geeta Rao Joined Jun 2026 4 months ago

This is very critical. For HER2-positive, recurrence risk is often highest in the first few years, sometimes up to 5 years after treatment. Please, please, do not ignore any unusual symptoms or skip your follow-up appointments. I ignored a small persistent cough once, and I still regret it. Timely check-ups are literally life-saving.

Sunil Kumar Sunil Kumar Joined Jan 2026 7 months ago

This is a serious concern, and my heart goes out to anyone dealing with it. For HER2-positive breast cancer, doctors usually say the highest risk for recurrence is in the initial years after treatment, maybe up to 5 years. While it's important to keep up with medical advice, I also believe in staying strong mentally and maintaining a healthy lifestyle with good food and light activities. Take care.

Related reads

All articles
Kavita Desai Kavita Desai Joined Feb 2026 7 months ago

Speaking from a professional background, for HER2-positive breast cancer, recurrence risk is generally higher in the early years following initial treatment, especially in the first 2-5 years. However, with targeted therapies like trastuzumab, recurrence rates have significantly reduced. The key is strict adherence to your treatment plan and regular, vigilant follow-ups with your oncologist. They will guide you through the surveillance schedule.

Evidence-based health, reviewed by clinicians. Free, weekly.